Suvendu Giri

机构：Weizmann Institute of Science · ORCID：0000-0002-7595-1359

发表论文 43 篇 · 总被引 302 次 · h-index 8

代表论文

AXL and Error-Prone DNA Replication Confer Drug Resistance and Offer Strategies to Treat EGFR-Mutant Lung Cancer (2022 · Cancer Discovery · 被引 109)
Green Synthesis of Silver Nanoparticles Using the Leaf Extract of the Medicinal Plant, Uvaria narum and Its Antibacterial, Antiangiogenic, Anticancer and Catalytic Properties (2023 · Antibiotics · 被引 89)
L858R emerges as a potential biomarker predicting response of lung cancer models to anti-EGFR antibodies: Comparison of osimertinib vs. cetuximab (2023 · Cell Reports Medicine · 被引 16)
Increased Plasma Nitrite and von Willebrand Factor Indicates Early Diagnosis of Vascular Diseases in Chemotherapy Treated Cancer Patients (2018 · Cardiovascular Toxicology · 被引 16)
A bispecific antibody targeting EGFR and AXL delays resistance to osimertinib (2024 · Cell Reports Medicine · 被引 15)
Host-Dependent Phenotypic Resistance to EGFR Tyrosine Kinase Inhibitors (2021 · Cancer Research · 被引 15)